日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor Cell-Intrinsic Decr2 Regulates Ferroptosis and Immunotherapy Efficacy.

肿瘤细胞内在的 Decr2 调节铁死亡和免疫疗法疗效

Li Shuyin, Shapiro Jason W, Shah Hardik, Higgs Emily F, Xie Lishi, Li Yaopeng, Zha Yuanyuan, Trujillo Jonathan, Cabanov Alexandra, Jones Tyler A, Flood Blake, Hatogai Ken, Tonea Ruxandra, Kline Justin, Gajewski Thomas F

Wilms tumor reveals DNA repair gene hyperexpression is linked to lack of tumor immune infiltration

威尔姆斯肿瘤研究揭示DNA修复基因过度表达与肿瘤免疫浸润不足有关。

Higgs, Emily F; Bao, Riyue; Hatogai, Ken; Gajewski, Thomas F

Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial

帕博利珠单抗单药治疗既往未接受治疗的晚期肝细胞癌:来自开放标签 II 期 KEYNOTE-224 试验的数据

Verset, Gontran; Borbath, Ivan; Karwal, Mark; Verslype, Chris; Van Vlierberghe, Hans; Kardosh, Adel; Zagonel, Vittorina; Stal, Per; Sarker, Debashis; Palmer, Daniel H; Vogel, Arndt; Edeline, Julien; Cattan, Stephane; Kudo, Masatoshi; Cheng, Ann-Lii; Ogasawara, Sadahisa; Daniele, Bruno; Chan, Stephen L; Knox, Jennifer J; Qin, Shukui; Siegel, Abby B; Chisamore, Michael; Hatogai, Ken; Wang, Anran; Finn, Richard S; Zhu, Andrew X

Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma

原发肿瘤不同部位免疫微环境与食管鳞状细胞癌临床结局的关系

Hatogai, Ken; Fujii, Satoshi; Kitano, Shigehisa; Kojima, Takashi; Daiko, Hiroyuki; Yoshino, Takayuki; Ohtsu, Atsushi; Takiguchi, Yuichi; Doi, Toshihiko; Ochiai, Atsushi

The Tumor Microenvironment of Bladder Cancer

膀胱癌的肿瘤微环境

Hatogai, Ken; Sweis, Randy F

Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy

肾细胞癌下腔静脉肿瘤血栓对新辅助免疫疗法的完全缓解

Labbate, Craig; Hatogai, Ken; Werntz, Ryan; Stadler, Walter M; Steinberg, Gary D; Eggener, Scott; Sweis, Randy F

Pathological tumor regression grade of metastatic tumors in lymph node predicts prognosis in esophageal cancer patients

淋巴结转移瘤的病理肿瘤退缩分级可预测食管癌患者的预后

Kadota, Tomohiro; Hatogai, Ken; Yano, Tomonori; Fujita, Takeo; Kojima, Takashi; Daiko, Hiroyuki; Fujii, Satoshi

Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers

罕见癌症、儿童癌症和常见癌症分子亚型抗癌疗法的全球开发

Lyerly, H Kim; Ren, Jun; Canetta, Renzo; Kim, Gi Hyun; Nagai, Sumimasa; Yamaguchi, Tomohiro; Hatogai, Ken; Katayama, Hiroshi; Da Rocha Dias, Silvy; McManus, Daniel; Soltys, Kathy; Yang, Zhimin; Olopade, Olufumilayo; Goodman, Nancy; Reaman, Greg; Gross, Thomas

Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma

食管鳞状细胞癌内镜活检标本与手术切除标本中PIK3CA突变的一致性

Hatogai, Ken; Fujii, Satoshi; Kojima, Takashi; Daiko, Hiroyuki; Doi, Toshihiko; Ohtsu, Atsushi; Ochiai, Atsushi; Takiguchi, Yuichi; Yoshino, Takayuki

Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma

食管鳞状细胞癌的大规模综合免疫组织化学生物标志物分析

Hatogai, Ken; Fujii, Satoshi; Kojima, Takashi; Daiko, Hiroyuki; Nomura, Shogo; Doi, Toshihiko; Kitano, Shigehisa; Ohtsu, Atsushi; Takiguchi, Yuichi; Yoshino, Takayuki; Ochiai, Atsushi